Boehringer Ingelheim registers Phase 1 bioequivalence trial for vicadrostat/empagliflozinSep 30Weekly roundup, 4 itemsBoehringer Ingelheimempagliflozin
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig, pumitamig in SCLCSep 28Trial updateBioNTech SEBoehringer Ingelheim
Boehringer Ingelheim registers Phase 3 VERANDA-IIM trial of nerandomilast in myositisAug 27Trial updateBoehringer Ingelheimnerandomilast
Boehringer registers Phase III survodutide trial in type 2 diabetesAug 10Trial updateBoehringer Ingelheim
Boehringer Ingelheim registers Phase I trial of immunotherapy BI 3822971 in solid tumorsAug 4Trial updateBoehringer Ingelheim
Boehringer Ingelheim posts completed bioequivalence trial of two pramipexole tablet formulationsJul 27Trial updateBoehringer Ingelheimpramipexole
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig with Zai Lab's ZL-1310 in SCLCJul 16Trial updateBoehringer IngelheimZai Lab (Shanghai) Co., Ltd.
Boehringer Ingelheim registers Phase I mass balance trial for BI 3034701Jul 16Trial updateBoehringer Ingelheim
Sign inSign in